The growth in the historic period can be attributed to increasing infertility prevalence among women, growing awareness of fertility treatment options, expansion of clinical gynecology services, availability of hormone-based infertility drugs, rising maternal age trends.
The growth in the forecast period can be attributed to increasing demand for assisted reproductive technologies, rising investments in fertility care infrastructure, growing focus on personalized hormone dosing, expansion of fertility treatment access in emerging markets, increasing clinical research in reproductive endocrinology. Major trends in the forecast period include increasing adoption of hormonal fertility therapies, rising demand for assisted reproductive treatments, growing use of urine-derived gonadotropins, expansion of specialized fertility clinics, enhanced focus on personalized ovulation induction protocols.
The increasing prevalence of infertility is expected to drive the growth of the Pergonal market. Infertility refers to the inability to conceive or carry a pregnancy to term, and its rise can be attributed to factors such as delayed childbearing, lifestyle choices, environmental toxins, and the increasing prevalence of medical conditions like polycystic ovary syndrome (PCOS) and endometriosis. Pergonal aids in treating infertility by stimulating ovulation through its combination of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), encouraging egg production in women with ovulatory dysfunction. For example, in April 2023, the World Health Organization (WHO) reported that approximately 17.5% of the global adult population, or about 1 in 6 individuals, face infertility. Consequently, the rising prevalence of infertility is contributing to the growth of the Pergonal market.
The increasing adoption of IVF procedures is expected to drive the growth of the Pergonal market. IVF (in vitro fertilization) procedures are medical treatments that help individuals or couples conceive by fertilizing an egg with sperm outside the body and then implanting the resulting embryo into the uterus. The adoption of IVF is on the rise as more people delay parenthood for reasons related to career, education, or social factors, leading to age-related fertility decline and greater reliance on fertility treatments. Pergonal aids IVF procedures by stimulating the ovaries to produce multiple mature eggs, increasing the likelihood of successful fertilization and embryo development. For example, in June 2025, the Human Fertilisation & Embryology Authority, a UK-based independent regulator of fertility treatment, reported that in 2023, 52,400 patients underwent over 77,500 IVF cycles at licensed fertility clinics in the UK. The number of egg freezing cycles rose from 4,700 in 2022 to 6,900 in 2023, accounting for 7% of all cycles. Therefore, the growing adoption of IVF procedures is contributing to the expansion of the Pergonal market.
The growing healthcare expenditure is also expected to fuel the growth of the Pergonal market. Healthcare spending is driven by factors such as the rising prevalence of chronic diseases, advancements in medical technologies, aging populations, and increasing demand for quality healthcare services. Higher healthcare spending helps improve access to advanced fertility treatments and increases the affordability of assisted reproductive technologies for patients. For instance, in May 2023, the Office for National Statistics, a UK-based government department, reported a 5.6% increase in healthcare spending in the UK between 2022 and 2023, compared to just 0.9% in 2022. The UK's healthcare expenditure reached around $317.63 billion (£292 billion) in 2023. Therefore, the growing healthcare expenditure is driving the growth of the Pergonal market.
Major companies operating in the pergonal market are Merck KGaA.
North America was the largest region in the pergonal market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pergonal market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pergonal market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs are impacting the pergonal market by increasing costs associated with imported biologic processing materials, pharmaceutical-grade reagents, sterile packaging components, and cold-chain logistics required for hormone-based fertility drugs. Hospitals and fertility clinics in North America and Europe are most affected due to reliance on imported raw materials and specialized biologic manufacturing inputs, while Asia-Pacific faces higher distribution and storage costs. These tariffs contribute to elevated treatment costs and slower patient adoption rates. However, they are also encouraging localized biologics manufacturing, regional sourcing of pharmaceutical inputs, and increased investments in domestic fertility drug production capabilities.
The pergonal market research report is one of a series of new reports that provides pergonal market statistics, including pergonal industry global market size, regional shares, competitors with a pergonal market share, detailed pergonal market segments, market trends and opportunities, and any further data you may need to thrive in the pergonal industry. This pergonal market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pergonal is a biologic drug that contains a combination of human menopausal gonadotropin (hMG), which includes both luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It is primarily used in fertility treatments to stimulate ovulation in women who have difficulty conceiving due to anovulation. Derived from the urine of postmenopausal women, it works by stimulating the ovaries to produce eggs.
The main indications for Pergonal include infertility treatment, hypogonadism, and ovarian stimulation. Infertility is defined as the inability of a couple to conceive after at least one year of trying without using contraception. Distribution channels for Pergonal include pharmacies and online pharmacies, while the end users are typically hospitals, fertility clinics, and home care settings.
The pergonal market consists of sales of menotropins, luteinizing hormone, and follicle-stimulating hormones. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The growth in the forecast period can be attributed to increasing demand for assisted reproductive technologies, rising investments in fertility care infrastructure, growing focus on personalized hormone dosing, expansion of fertility treatment access in emerging markets, increasing clinical research in reproductive endocrinology. Major trends in the forecast period include increasing adoption of hormonal fertility therapies, rising demand for assisted reproductive treatments, growing use of urine-derived gonadotropins, expansion of specialized fertility clinics, enhanced focus on personalized ovulation induction protocols.
The increasing prevalence of infertility is expected to drive the growth of the Pergonal market. Infertility refers to the inability to conceive or carry a pregnancy to term, and its rise can be attributed to factors such as delayed childbearing, lifestyle choices, environmental toxins, and the increasing prevalence of medical conditions like polycystic ovary syndrome (PCOS) and endometriosis. Pergonal aids in treating infertility by stimulating ovulation through its combination of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), encouraging egg production in women with ovulatory dysfunction. For example, in April 2023, the World Health Organization (WHO) reported that approximately 17.5% of the global adult population, or about 1 in 6 individuals, face infertility. Consequently, the rising prevalence of infertility is contributing to the growth of the Pergonal market.
The increasing adoption of IVF procedures is expected to drive the growth of the Pergonal market. IVF (in vitro fertilization) procedures are medical treatments that help individuals or couples conceive by fertilizing an egg with sperm outside the body and then implanting the resulting embryo into the uterus. The adoption of IVF is on the rise as more people delay parenthood for reasons related to career, education, or social factors, leading to age-related fertility decline and greater reliance on fertility treatments. Pergonal aids IVF procedures by stimulating the ovaries to produce multiple mature eggs, increasing the likelihood of successful fertilization and embryo development. For example, in June 2025, the Human Fertilisation & Embryology Authority, a UK-based independent regulator of fertility treatment, reported that in 2023, 52,400 patients underwent over 77,500 IVF cycles at licensed fertility clinics in the UK. The number of egg freezing cycles rose from 4,700 in 2022 to 6,900 in 2023, accounting for 7% of all cycles. Therefore, the growing adoption of IVF procedures is contributing to the expansion of the Pergonal market.
The growing healthcare expenditure is also expected to fuel the growth of the Pergonal market. Healthcare spending is driven by factors such as the rising prevalence of chronic diseases, advancements in medical technologies, aging populations, and increasing demand for quality healthcare services. Higher healthcare spending helps improve access to advanced fertility treatments and increases the affordability of assisted reproductive technologies for patients. For instance, in May 2023, the Office for National Statistics, a UK-based government department, reported a 5.6% increase in healthcare spending in the UK between 2022 and 2023, compared to just 0.9% in 2022. The UK's healthcare expenditure reached around $317.63 billion (£292 billion) in 2023. Therefore, the growing healthcare expenditure is driving the growth of the Pergonal market.
Major companies operating in the pergonal market are Merck KGaA.
North America was the largest region in the pergonal market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pergonal market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pergonal market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs are impacting the pergonal market by increasing costs associated with imported biologic processing materials, pharmaceutical-grade reagents, sterile packaging components, and cold-chain logistics required for hormone-based fertility drugs. Hospitals and fertility clinics in North America and Europe are most affected due to reliance on imported raw materials and specialized biologic manufacturing inputs, while Asia-Pacific faces higher distribution and storage costs. These tariffs contribute to elevated treatment costs and slower patient adoption rates. However, they are also encouraging localized biologics manufacturing, regional sourcing of pharmaceutical inputs, and increased investments in domestic fertility drug production capabilities.
The pergonal market research report is one of a series of new reports that provides pergonal market statistics, including pergonal industry global market size, regional shares, competitors with a pergonal market share, detailed pergonal market segments, market trends and opportunities, and any further data you may need to thrive in the pergonal industry. This pergonal market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pergonal is a biologic drug that contains a combination of human menopausal gonadotropin (hMG), which includes both luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It is primarily used in fertility treatments to stimulate ovulation in women who have difficulty conceiving due to anovulation. Derived from the urine of postmenopausal women, it works by stimulating the ovaries to produce eggs.
The main indications for Pergonal include infertility treatment, hypogonadism, and ovarian stimulation. Infertility is defined as the inability of a couple to conceive after at least one year of trying without using contraception. Distribution channels for Pergonal include pharmacies and online pharmacies, while the end users are typically hospitals, fertility clinics, and home care settings.
The pergonal market consists of sales of menotropins, luteinizing hormone, and follicle-stimulating hormones. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pergonal Market Characteristics
3. Pergonal Market Supply Chain Analysis
4. Global Pergonal Market Trends and Strategies
5. Pergonal Market Analysis of End Use Industries
7. Global Pergonal Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pergonal Total Addressable Market (TAM) Analysis for the Market
9. Pergonal Market Segmentation
10. Pergonal Market Regional and Country Analysis
11. Asia-Pacific Pergonal Market
12. China Pergonal Market
13. India Pergonal Market
14. Japan Pergonal Market
15. Australia Pergonal Market
16. South Korea Pergonal Market
17. Western Europe Pergonal Market
18. UK Pergonal Market
19. Germany Pergonal Market
20. France Pergonal Market
21. Eastern Europe Pergonal Market
22. North America Pergonal Market
23. USA Pergonal Market
24. Canada Pergonal Market
25. South America Pergonal Market
26. Middle East Pergonal Market
27. Africa Pergonal Market
29. Pergonal Market Competitive Landscape and Company Profiles
32. Pergonal Market High Potential Countries, Segments and Strategies
33. Appendix
Executive Summary
Pergonal Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pergonal market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pergonal? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pergonal market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Indication: Infertility Treatment; Hypogonadism; Ovarian Stimulation2) By Distribution Channel: Pharmacies; Online Pharmacies
3) By End User: Hospitals; Fertility Clinics; Home Care
Companies Mentioned: Merck KGaA
Countries: Australia; India; China; South Korea; Japan; UK; France; Germany; USA; Canada.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pergonal market report include:- Merck KGaA
